Latest news with #ProtonTherapy
Yahoo
24-07-2025
- Business
- Yahoo
Market to Reach $10.2 Billion by 2030 - Surge in Awareness Campaigns on Early Cancer Detection Supports Growth
The Radiation Oncology market is propelled by advancements in precise, innovative therapies like IMRT and proton therapy, driven by rising global cancer incidences. Growing AI integration, personalized oncology, and adaptive radiotherapy enhance treatment efficacy. Emerging markets and infrastructure investments offer key growth opportunities. Radiation Oncology Market Dublin, July 24, 2025 (GLOBE NEWSWIRE) -- The "Radiation Oncology - Global Strategic Business Report" report has been added to global market for Radiation Oncology was estimated at US$7.9 Billion in 2024 and is projected to reach US$10.2 Billion by 2030, growing at a CAGR of 4.3% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The growth in the radiation oncology market is driven by several factors, including the global rise in cancer prevalence, advancements in radiotherapy technologies, and increasing healthcare investments in oncology infrastructure. Rising incidence of complex and treatment-resistant cancers is propelling demand for precision-focused modalities like proton therapy and stereotactic radiotherapy. At the same time, technological convergence between AI, imaging, and radiotherapy is facilitating personalized treatment planning and outcome monitoring, which enhances clinical effectiveness and operational funding and public-private partnerships are accelerating the deployment of radiotherapy infrastructure in both developed and emerging regions. Additionally, expanding insurance coverage for advanced radiotherapy procedures and increasing awareness about early cancer detection are supporting treatment uptake. Ongoing clinical trials exploring novel combinations of immunotherapy with radiation are expected to open new therapeutic frontiers in the years ahead. Together, these drivers are positioning radiation oncology not only as a cornerstone of modern cancer therapy but also as a field undergoing continuous technological and clinical innovation, with strong growth prospects globally. How Is Radiation Oncology Evolving in Response to Cancer Care Demands?Radiation oncology continues to be a cornerstone in the multidisciplinary management of cancer, with ongoing innovations enhancing both efficacy and precision in targeting malignant tissues. The field has shifted significantly from conventional radiotherapy to highly advanced techniques such as intensity-modulated radiation therapy (IMRT), stereotactic radiosurgery (SRS), image-guided radiation therapy (IGRT), and proton beam therapy. These modalities allow for accurate dose delivery that spares surrounding healthy tissue, reduces side effects, and improves patient outcomes. Growing cancer incidence worldwide, coupled with an aging population, is pushing healthcare systems to expand radiation oncology infrastructure and adoption of personalized oncology, where treatment is tailored based on tumor genetics and radiomic data, is further redefining treatment planning. Integration of artificial intelligence and machine learning algorithms into radiation oncology software is facilitating adaptive radiotherapy, which adjusts treatment in real time based on patient response and anatomical changes. Additionally, advancements in radiobiology and hypofractionation protocols are enabling shorter treatment durations with equal or improved efficacy, enhancing both throughput and patient convenience. These developments are driving clinical and operational transformation in radiation oncology centers Technologies and Modalities Are Shaping Modern Radiation Oncology Practice?Cutting-edge technologies are transforming the landscape of radiation oncology, with linear accelerators (LINACs), proton therapy units, brachytherapy equipment, and robotic radiosurgery platforms gaining prominence. LINAC systems now incorporate multi-leaf collimators (MLCs), volumetric modulated arc therapy (VMAT), and onboard imaging to deliver precise tumor targeting in fewer sessions. Proton therapy, which deposits most of its energy at the Bragg peak, is witnessing rapid adoption in pediatric oncology and complex tumor cases due to its minimal collateral damage and reduced long-term motion management techniques such as respiratory gating and real-time tumor tracking are being incorporated to address organ movement during therapy, particularly in lung and gastrointestinal cancers. Brachytherapy is gaining renewed interest for cervical, prostate, and breast cancers, thanks to its high dose localization and shortened treatment duration. Integration of MRI and PET imaging into planning systems enhances tumor delineation and adaptive treatment planning. Additionally, emerging radiopharmaceuticals in targeted radionuclide therapy are expanding treatment options for metastatic cancers, particularly in prostate and neuroendocrine Are Hospitals and Cancer Centers Adapting to the Radiation Oncology Revolution?Radiation oncology departments are undergoing significant upgrades to accommodate new technologies, workflow automation, and multidisciplinary integration. Hospitals are investing in hybrid operating suites, advanced treatment planning software, and oncology information systems (OIS) to streamline patient data management and outcome tracking. Additionally, collaborations between radiation oncologists, medical physicists, dosimetrists, and IT professionals are being formalized into cross-functional teams to optimize treatment planning and delivery. Academic medical centers are leading the charge in deploying AI-guided adaptive planning tools and cloud-based contouring platforms that enhance precision while reducing planning and workforce development are also critical components of adaptation. The complexity of modern radiotherapy requires constant upskilling in areas such as image interpretation, machine calibration, and cybersecurity for networked oncology systems. Moreover, hospitals are adopting patient-centered models that integrate psychosocial support, symptom tracking, and remote consultations into radiation oncology care pathways. Global oncology networks and tele-radiation platforms are helping extend advanced radiotherapy services to underserved regions, reducing disparities in cancer treatment access. These operational and clinical upgrades are central to radiation oncology's evolution from a procedural specialty into a fully integrated, data-driven care model. Why You Should Buy This Report: Detailed Market Analysis: Access a thorough analysis of the Global Radiation Oncology Market, covering all major geographic regions and market segments. Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies. Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Radiation Oncology Market. Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions. Key Insights: Market Growth: Understand the significant growth trajectory of the External Beam Radiation Therapy segment, which is expected to reach US$3.6 Billion by 2030 with a CAGR of a 3.3%. The Brachytherapy segment is also set to grow at 5.5% CAGR over the analysis period. Regional Analysis: Gain insights into the U.S. market, estimated at $2.2 Billion in 2024, and China, forecasted to grow at an impressive 7.6% CAGR to reach $2.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific. Report Features: Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030. In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Company Profiles: Coverage of players such as Accuray Incorporated, Bionix Radiation Therapy, LLC, Brainlab AG, Canon Medical Systems Corporation, Curium and more. Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments. Scope of Study: Treatment Type (External Beam Radiation Therapy, Brachytherapy, Systemic Radiation Therapy, Stereotactic Radiosurgery) Technology (Linear Accelerators Technology, Radioisotopes Technology, Particle Therapy Technology, Tomotherapy Technology) Application (Breast Cancer Application, Prostate Cancer Application, Lung Cancer Application, Brain Cancer Application, Head & Neck Cancer Application) End-Use (Hospitals End-Use, Outpatient Clinics End-Use, Cancer Research Institutes End-Use, Ambulatory Surgery Centers End-Use) Key Attributes: Report Attribute Details No. of Pages 488 Forecast Period 2024 - 2030 Estimated Market Value in 2024 7.9 Billion Forecasted Market Value by 2030 10.2 Billion Compound Annual Growth Rate 4.3% Regions Covered Global Key Topics Covered: MARKET OVERVIEW Influencer Market Insights World Market Trajectories Tariff Impact on Global Supply Chain Patterns Radiation Oncology - Global Key Competitors Percentage Market Share in 2025 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E) MARKET TRENDS & DRIVERS Rising Cancer Incidence Worldwide Throws the Spotlight on Advanced Radiotherapy Modalities Technological Advancements in Image-Guided Radiation Therapy Strengthen Precision Treatment Capabilities Expansion of Linear Accelerator Installations in Emerging Markets Drives Equipment Uptake Integration of Artificial Intelligence in Treatment Planning Accelerates Adoption of Adaptive Therapy Solutions Rising Utilization of Stereotactic Radiosurgery Expands Clinical Applications in Brain and Spine Tumors Growth in Proton and Heavy Ion Therapy Centers Drives Demand for High-End Oncology Infrastructure Collaborations Between Research Institutions and Hospitals Fuel Personalized Oncology Approaches Favorable Reimbursement Policies for Radiation Oncology Procedures Sustain Market Accessibility Growing Adoption of Hypofractionated Radiotherapy Enhances Patient Convenience and Throughput Emergence of Real-Time Tumor Tracking and Motion Management Improves Clinical Outcomes Rising Investments in Hybrid Radiotherapy Systems Strengthen Business Case for Multi-Modality Platforms Expansion of Cancer Care Networks and Outreach Programs Boosts Regional Equipment Penetration Increased Focus on Pediatric Radiation Safety Drives Innovation in Dose Optimization Tools Partnerships With Academic Medical Centers Accelerate Development of Evidence-Based Protocols Government Grants for Cancer Treatment Infrastructure Upgrade Promote Public Hospital Modernization Shift Toward Outpatient Radiotherapy Centers Enhances Equipment Turnaround and Affordability Development of Cloud-Based Treatment Planning Systems Improves Workflow and Collaboration Integration of Immunotherapy and Radiotherapy Approaches Strengthens Clinical Trial Pipelines Surge in Awareness Campaigns on Early Cancer Detection Supports Radiation Oncology Growth AI-Enabled Radiomics and Predictive Modeling Drive Precision Medicine in Radiation Treatment FOCUS ON SELECT PLAYERS |Some of the 44 companies featured in this Radiation Oncology market report include: Accuray Incorporated Bionix Radiation Therapy, LLC Brainlab AG Canon Medical Systems Corporation Curium Eckert & Ziegler BEBIG Elekta AB GE Healthcare Hitachi Ltd. IBA (Ion Beam Applications SA) Isoray Inc. Mevion Medical Systems Inc. Nanobiotix Nordion Inc. Optivus Proton Therapy Inc. Panacea Medical Technologies Pvt. Ltd. RefleXion Medical RaySearch Laboratories AB Siemens Healthineers AG Sirtex Medical Limited Varian Medical Systems (Siemens) ViewRay Technologies, Inc. For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Radiation Oncology Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
7NEWS
18-06-2025
- Health
- 7NEWS
Australian kids with cancer forced overseas for treatment as proton therapy centre sits empty in Adelaide
It was meant to revolutionise cancer treatment for Australian children. Instead, Adelaide 's state-of-the-art Australian Bragg Centre for Proton Therapy now sits pretty much empty, and is likely to remain so for many years to come. WATCH THE VIDEO ABOVE: Lack of cancer treatment forces Australian families to seek care abroad. Know the news with the 7NEWS app: Download today It means hundreds of Australian families already navigating the hardest point in their lives after being told their kid has cancer will have to deal with endless paperwork for government grants or raise thousands of dollars themselves before packing up their lives and travelling to the United States for treatment. Opposition health spokesperson Anne Ruston declared it an 'absolute national shame and an abject failure'. She said many children and babies 'likely will die as a result of not being able to get access to the technology that was promised to them'. The project was promised eight years ago by the federal Liberal and state government. But last year the South Australian Labor government tore up the contract with the US company supplying the proton beam machine over funding issues. An auditor general report into the decision has since found significant 'gaps' in the way the state government managed the project. 'Including the need for... effective oversight, project management and risk management arrangements, reflecting a project that is high risk, has a significant cost and has national consequences,' the report said. South Australian Premier Peter Malinauskas told 7NEWS: 'We can't fix the errors of the past, we just have to focus on a way we can get through this rather complex policy challenge.' But with more than $100 million of public money already spent and no clear timeline for completion, the cost to taxpayers, and to Australian families, is mounting. Federal Health Minister Mark Butler said 'we are trying to work out really how much of that money is going to be able to be recouped', if any. 'But it seems quite clear to me on the best advice I have from the department that there is going to be a significant taxpayer loss here,' he said. He warned that it could still be years before Australia has a functioning proton therapy unit, and pointed the finger at earlier decisions made under the former Marshall Liberal government in South Australia and the Turnbull Liberal government federally for choosing a controversial company unable to deliver the machine. Ruston rejected the attempt to shift blame, saying 'it is a sad indictment that you would have a health minister who is about to enter his second term who is still blaming previous governments for the failures that are occurring on his watch'. While politicians argue, and bureaucrats continue to release reports, almost 1000 Australian families are trying to raise enough money to receive lifesaving treatment in America. Five-year-old Lenna Housseini was recently knocked back by the federal government's Medical Overseas Treatment Program, which helps Australians with life-threatening medical conditions access treatment overseas when it is not available here. Her parents would need to raise $500,000 privately for her to go. Without the time to do so, she will undergo treatment for Malignant Rhabdoid Tumour in Australia. While the X-ray radiation here could save her life, there is only a 40 per cent chance she will survive and if she does pull through, she may struggle to speak. 'It's too late to complain, it's too late to do anything, it's too late to even have the regret, because we don't have time to have regret, we have to stay positive,' her father Amin Housseini said earlier this week.
West Australian
16-06-2025
- Health
- West Australian
Perth girl Lenna Housseini diagnosed with extremely rare and aggressive cancer
A simple question at the dinner table about a bump on five-year-old Lenna's neck changed the Housseini's lives forever. 'Does it hurt when I press it' her father Amin asked. It didn't. That's because the lump is an extremely rare and aggressive cancer known as MRT or Malignant Rhabdoid Tumour. The tumour at the base of her tongue is so rare it hasn't been seen in Australia in decades. It's so aggressive, Lenna has gone from being a happy and healthy five-year-old to having a life-threatening condition in three months. There's only a 40 percent chance the little girl from Melville will survive and if she pulls through, she will struggle to speak. Her parents had their bags packed last week to take her to the United States for cutting edge treatment. Her Perth doctors had recommended her for Proton Therapy in Florida. But they were knocked back by the Federal Government's Medical Overseas Treatment Program, as the cancer is so rare, there's not enough evidence the overseas treatment will be successful. Her parents could try and raise half a million dollars to send her privately, but it's too late. It would take weeks to reapply, and Lenna simply doesn't have that long. 'It's too late to complain, it's too late to do anything, it's too late to even have the regret, because we don't have time to have regret, we have to stay positive,' Amin Housseini said. Fundraiser by Friends of the Hosseini's : Light to Lenna The Proton therapy offered in the US is precise, it can pinpoint a tumour and kill only the cancer cells. It's often used in small children and for cancers in the head, spinal cord, and heart, where there are vital organs. The x-ray radiation we have in Australia, is more rudimentary. The larger beam kills the cancer, but also the healthy cells around it. It could save Lenna's life, but there's a risk of lifelong disability. The 6cm tumour is at the base of her tongue, meaning parts of her jaw and tongue will be affected by the radiation and that will affect her speech. 'Her jaw may not grow in the future, as naturally,' her mother, Mahsa Shafiei, said. 'It's going to affect her tongue and all the cells in her tongue, and she might not be able to move it.' The rejection from the Medical Overseas Treatment Program is heart-wrenching. But it's a decision the body should never have had to make. In 2017, the federal government announced it'll build the $500 million-dollar Australian Bragg Centre for Proton Therapy in Adelaide. There's a custom bunker 16m underground made to hold the machine, but it's empty. Last year the Health Department and South Australian government tore up the contract American company building the machine. They had spent tens of millions in progress payments, but there were funding disputes and little progress. Ultimately the State and Federal government's lost confidence in the manufacturers ability to deliver. Federal Health Minister Mark Butler telling 7NEWS his government is still committed to bringing Proton Therapy to Australia. 'A proton therapy unit is a really important part of the suite of cancer treatment options, particularly for kids, but over time for adults, here in Australia,' he said. 'The South Australian Government is doing the lead work to see whether another type of unit from another supplier can be sourced.' But those contract negotiations are starting from scratch and meaning Australian Proton Therapy is years, if not decades away. Time five-year-old Lenna does not have. Her family now focusing on the basics as she goes through radiation here in Perth. 'Eat, drink and smile' Lenna said are her goals for each day.
Yahoo
19-03-2025
- Health
- Yahoo
WellSpan Health – Innovations & Advancements in Cancer Treatment
A York County business owner is sharing his story of hope after completing an innovative cancer treatment at WellSpan York Hospital. John Grim has been battling prostate cancer for nearly seven years, and after multiple treatments failed, doctors offered him a chance to try something knew. Janel Knight told us his story this morning. John Grim's doctor and Medical Director of Radiation Oncology at WellSpan Health, Dr. Navesh Sharma, spoke with Amy about Pluvicto, new cancer treatments being offered at WellSpan Health, Proton Therapy, and more. As part of today's special Good Day PA, abc27 and WellSpan Health hosted a live webchat. Dr. Jaganmohan Poli, Radiation Oncologist at WellSpan Health, answered viewer submitted questions about radiation oncology and radiation therapy. Amy spoke with Dr. Scott Tiedbohl, Thoracic Surgeon at WellSpan Health, to learn more about lung cancer screening, advancements in technology and treatments, and how these benefit patients and the community. WellSpan Cancer Institute is proud of it's efforts to truly listen to patients, allowing experts to customize treatment options while offering compassionate care. Amy spoke with Dr. Nik Korgaonkar to learn more. Dr. Poli joined Janel again later in the show to answer more viewer questions. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
